Epithelial-mesenchymal transition (EMT) is a process that enables epithelial cells to gain migratory and invasive capabilities, playing a crucial role in tumor metastasis. This review summarizes the role of EMT in the metastatic cascade, highlighting key findings from studies in cancer cell lines, genetic mouse models, and clinical human breast cancer tissues. EMT is driven by various signaling pathways, including TGF-β, WNT, NOTCH, and growth factor receptor tyrosine kinases. Key EMT transcription factors, such as SNAIL, TWIST, and ZEB, regulate the transition by repressing E-cadherin expression and promoting mesenchymal gene expression. EMT enables tumor cells to invade, survive in circulation, and establish metastases in distant sites. Studies in tumor cell lines and mouse models have shown that EMT is essential for metastasis, with EMT-TFs like SNAIL1 and TWIST1 being critical regulators. However, the role of EMT in metastasis remains controversial, as some studies suggest that tumor cells may metastasize without undergoing EMT. Human patient studies have shown that EMT markers are associated with poor prognosis in various cancers, and circulating tumor cells (CTCs) often exhibit EMT characteristics. Targeting EMT may offer therapeutic benefits in metastatic cancer, although challenges remain in developing effective EMT inhibitors. Overall, EMT is a complex and dynamic process that plays a significant role in tumor metastasis, and further research is needed to fully understand its mechanisms and therapeutic potential.Epithelial-mesenchymal transition (EMT) is a process that enables epithelial cells to gain migratory and invasive capabilities, playing a crucial role in tumor metastasis. This review summarizes the role of EMT in the metastatic cascade, highlighting key findings from studies in cancer cell lines, genetic mouse models, and clinical human breast cancer tissues. EMT is driven by various signaling pathways, including TGF-β, WNT, NOTCH, and growth factor receptor tyrosine kinases. Key EMT transcription factors, such as SNAIL, TWIST, and ZEB, regulate the transition by repressing E-cadherin expression and promoting mesenchymal gene expression. EMT enables tumor cells to invade, survive in circulation, and establish metastases in distant sites. Studies in tumor cell lines and mouse models have shown that EMT is essential for metastasis, with EMT-TFs like SNAIL1 and TWIST1 being critical regulators. However, the role of EMT in metastasis remains controversial, as some studies suggest that tumor cells may metastasize without undergoing EMT. Human patient studies have shown that EMT markers are associated with poor prognosis in various cancers, and circulating tumor cells (CTCs) often exhibit EMT characteristics. Targeting EMT may offer therapeutic benefits in metastatic cancer, although challenges remain in developing effective EMT inhibitors. Overall, EMT is a complex and dynamic process that plays a significant role in tumor metastasis, and further research is needed to fully understand its mechanisms and therapeutic potential.